Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Raytest is a German life science and radiopharmaceutical instrumentation company best known for radioactivity detection, radio-HPLC flow monitors, quality-control systems, and laboratory software used in nuclear medicine, PET, and related research settings. Founded in 1980 in Straubenhardt, Germany, the company historically operated as Raytest, Isotopenmessgeräte GmbH and became part of the Elysia group in 2015, now operating as Elysia-raytest GmbH. Its portfolio includes radio-detectors, chromatography-connected radiation measurement systems, QC workflows for radiopharmaceutical production, and laboratory informatics tools. The company serves pharmaceutical, agrochemical, academic, and nuclear medicine customers globally and manufactures products in Germany and Belgium. Raytest is not a therapeutic drug developer; it is a commercial provider of instruments and software supporting radiopharmaceutical analysis and production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Raytest Isotopenmessgeräte.